Line 31: | Line 31: | ||
We visited the Research facility of the same major dairy company in the Netherlands to discuss our project with Arjen Nauta (Sr. Scientist Nutritional Sciences). Since our project focusses on detecting bacteriophages which can negatively impact various dairy production lines, we were excited to talk to a bacteriophage research expert in the dairy industry such as Arjen Nauta. He kindly discussed the issues he faces in his research concerning bacteriophages and provided us with helpful advice for our project. Arjen pointed out that the use of GMOs for the dairy industry is very tricky. Even though our detection device will not get in contact with the product, the factory still needs a permit to use it. This permit is accessible by the public and as the use of GMOs in Europe is still very controversial, they do not want the risk of a NGO getting hold of it. Our detection device could however be useful in their research laboratory. Current detection techniques are not able to detect new bacteriophages. If we could implement a way that new bacteriophage sequences can be obtained, this would give new opportunities for bacteriophage research. | We visited the Research facility of the same major dairy company in the Netherlands to discuss our project with Arjen Nauta (Sr. Scientist Nutritional Sciences). Since our project focusses on detecting bacteriophages which can negatively impact various dairy production lines, we were excited to talk to a bacteriophage research expert in the dairy industry such as Arjen Nauta. He kindly discussed the issues he faces in his research concerning bacteriophages and provided us with helpful advice for our project. Arjen pointed out that the use of GMOs for the dairy industry is very tricky. Even though our detection device will not get in contact with the product, the factory still needs a permit to use it. This permit is accessible by the public and as the use of GMOs in Europe is still very controversial, they do not want the risk of a NGO getting hold of it. Our detection device could however be useful in their research laboratory. Current detection techniques are not able to detect new bacteriophages. If we could implement a way that new bacteriophage sequences can be obtained, this would give new opportunities for bacteriophage research. | ||
+ | </div> | ||
+ | <hr class="small"> | ||
+ | |||
+ | |||
+ | <h3>Christian Hansen, Thomas Jansen - 13 September</h3> | ||
+ | <div style="text-align:left;"> | ||
+ | <p> | ||
+ | As part of considering the implications of our product and finding a possible potential market for it, we contacted Thomas Jansen from the Christian Hanssen company and had a skype call with him on the 13th of September. The company mostly deals with starter cultures and tests for the presence of bacterial phages. From our talk with him, we found out that the current go-to method for their company is doing a plaque assay and that when needed, they also use qPCR. Their test takes 2-3 days if everything works properly. He mentioned three points that were particularly relevant to us. First, that our product would be useful if it takes a few hours and around the same concentrations as we got from DSM. Secondly, that the device will be more useful if it can detect a specific strain. This is something we’ve taken into consideration in building our final product. By imputing different plasmids into our system or adjusting the plasmid for different strains, it will be able to detect specific strains if all works properly. Thirdly, that our device can also be used on the factory floor. Currently Chr-Hanssen offers phage detection as a free complementary product, but if the they had a test they can offer the customer at home that would be better. As our product contains GMO’s, European regulations prevent it from being used on the factory floor, we cannot currently offer this. Instead we will make our product as safe as possible as if it would be allowed. Based on this conversation, together with the impressions we received from conversations with other factory specialists and our factory visits, we decided to broaden our horizons and look beyond the dairy industry in Europe. | ||
+ | </p> | ||
</div> | </div> | ||
<hr class="small"> | <hr class="small"> |
Revision as of 13:07, 9 October 2017
Human Practices
What we did for our integrated human practices
- In short: how did we implement all the information we got from our interviews?
- We decided to make a product that is not in contact with the end product.
- We decided to use sequences from a … bacteriophage.
- We designed an on-site detection cartridge which is easy to use.
- We designed a program which can determine spacers for specific bacteriophages.
- We added a hydrogen peroxide compartment to the cartridge to ensure safe disposal.
Dairy Factory Workum - 10 August
Dairy Research Plant Wagening - 23 August
Christian Hansen, Thomas Jansen - 13 September
As part of considering the implications of our product and finding a possible potential market for it, we contacted Thomas Jansen from the Christian Hanssen company and had a skype call with him on the 13th of September. The company mostly deals with starter cultures and tests for the presence of bacterial phages. From our talk with him, we found out that the current go-to method for their company is doing a plaque assay and that when needed, they also use qPCR. Their test takes 2-3 days if everything works properly. He mentioned three points that were particularly relevant to us. First, that our product would be useful if it takes a few hours and around the same concentrations as we got from DSM. Secondly, that the device will be more useful if it can detect a specific strain. This is something we’ve taken into consideration in building our final product. By imputing different plasmids into our system or adjusting the plasmid for different strains, it will be able to detect specific strains if all works properly. Thirdly, that our device can also be used on the factory floor. Currently Chr-Hanssen offers phage detection as a free complementary product, but if the they had a test they can offer the customer at home that would be better. As our product contains GMO’s, European regulations prevent it from being used on the factory floor, we cannot currently offer this. Instead we will make our product as safe as possible as if it would be allowed. Based on this conversation, together with the impressions we received from conversations with other factory specialists and our factory visits, we decided to broaden our horizons and look beyond the dairy industry in Europe.